ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC35465-25mg |
|
1985606-14-1 |
Baloxavir marboxil
|
0 | C27H23F2N3O7S | |
GC35465-10mg |
|
1985606-14-1 |
Baloxavir marboxil
|
0 | C27H23F2N3O7S | |
GC35465-5mg |
|
1985606-14-1 |
Baloxavir marboxil
|
0 | C27H23F2N3O7S | |
GC35465-10mM (in 1mL DMSO) |
|
1985606-14-1 |
Baloxavir marboxil
|
0 | C27H23F2N3O7S | |
GC35463-5mg |
|
82475-03-4 |
Baicalin methyl ester
|
0 | C22H20O11 | |
GC35462-100mg |
|
859212-16-1 |
Bafetinib
|
0 | C30H31F3N8O | |
GC35462-50mg |
|
859212-16-1 |
Bafetinib
|
0 | C30H31F3N8O | |
GC35462-10mg |
|
859212-16-1 |
Bafetinib
|
0 | C30H31F3N8O | |
GC35462-5mg |
|
859212-16-1 |
Bafetinib
|
0 | C30H31F3N8O | |
GC35462-10mM (in 1mL DMSO) |
|
859212-16-1 |
Bafetinib
|
0 | C30H31F3N8O | |
GC35461-5mg |
|
— |
Bacterial Sortase Substrate III, Abz/DNP (TFA)
|
0 | C43H58N11F3O16 | |
GC35461-1mg |
|
— |
Bacterial Sortase Substrate III, Abz/DNP (TFA)
|
0 | C43H58N11F3O16 | |
GC35460-5mg |
|
— |
Bacterial Sortase Substrate III, Abz/DNP
|
0 | C41H57N11O14 | |
GC35460-1mg |
|
— |
Bacterial Sortase Substrate III, Abz/DNP
|
0 | C41H57N11O14 | |
GC35459-5mg |
|
620592-16-7 |
Bacopaside V
|
0 | C41H66O13 | |
GC35458-10mg |
|
382146-66-9 |
Bacopaside II
|
0 | C47H76O18 | |
GC35458-5mg |
|
382146-66-9 |
Bacopaside II
|
0 | C47H76O18 | |
GC35458-1mg |
|
382146-66-9 |
Bacopaside II
|
0 | C47H76O18 | |
GC35457-5mg |
|
382148-47-2 |
Bacopaside I
|
0 | C46H74O20S | |
GC35456-5mg |
|
178064-13-6 |
Bacopasaponin C
|
0 | C46H74O17 | |